Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
about
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmissionPharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionIn vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysisDevelopment of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, MozambiqueOptimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor SettingsAntiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysisPharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.
P2860
Q28481233-E591DEED-DE16-40B6-81F0-E4DFC1658395Q28481276-08DA0751-CF51-42F4-8726-1120FF860BC4Q28486262-4B049312-C78A-4948-83A3-C7F5319563F4Q28546418-87FBA0B3-062F-4E98-B2F6-BE0A2F895485Q28547109-7FD0AA8B-9902-43F1-A889-77E2305D8A3CQ34528801-481F1E6C-FE86-4AAD-B74C-6986BFD3C5BFQ34922985-1AD96602-41CE-468F-8931-18E474410687Q37126494-86D50644-20A2-4A45-90AB-C50D7C33FB77Q55299659-7973BA62-6A8B-414A-AB68-816FD2346838
P2860
Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Quantifying the impact of nevi ...... to predict clinical outcomes.
@ast
Quantifying the impact of nevi ...... to predict clinical outcomes.
@en
type
label
Quantifying the impact of nevi ...... to predict clinical outcomes.
@ast
Quantifying the impact of nevi ...... to predict clinical outcomes.
@en
prefLabel
Quantifying the impact of nevi ...... to predict clinical outcomes.
@ast
Quantifying the impact of nevi ...... to predict clinical outcomes.
@en
P2093
P2860
P356
P1476
Quantifying the impact of nevi ...... s to predict clinical outcomes
@en
P2093
P2860
P304
P356
10.1128/AAC.00741-11
P407
P577
2011-09-26T00:00:00Z